title: A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT & SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320: in regard to Sperduto et al.
authors.forename: H Ian
authors.initials: HI
authors.lastname: Robins
authors.forename: Anne
authors.initials: A
authors.lastname: O'Neill
authors.forename: Minesh
authors.initials: M
authors.lastname: Mehta
authors.forename: Stuart
authors.initials: S
authors.lastname: Grossman
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000628:therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D016371:Cranial Irradiation / Q000379:methods*; D003606:Dacarbazine / Q000031:analogs & derivatives*; D006801:Humans; D008175:Lung Neoplasms; D011799:Quinazolines / Q000627:therapeutic use*; D016634:Radiosurgery / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D003606:Dacarbazine